Skip to main content

Greg Challis Biography
















Greg Challis graduated with a BSc in Chemistry (1994) from Imperial College London and a DPhil in Organic Chemistry (1998) from the University of Oxford, for research carried out under the supervision of Prof. Sir Jack Baldwin FRS. He carried out postdoctoral research as a Wellcome Trust International Prize Travelling Research Fellow in the Department of Chemistry at Johns Hopkins University, USA, with Prof. Craig Townsend (1998-2000) and in the Department of Genetics at John Innes Centre, UK, with Prof. Keith Chater FRS (2000-2001). In 2001 he took up a lectureship in Chemical Biology in the Department of Chemistry at the University of Warwick. In 2003 he was promoted to Senior Lecturer and in 2006 he was promoted to Professor. In July 2016 he was appointed as the Warwick-Monash Professor of Sustainable Chemistry (Chemical and Synthetic Biology), a joint position between the Department of Chemistry at the University of Warwick, and the Department of Biochemistry and Molecular Biology at Monash University in Melbourne, Australia.

Challis has published more than 100 papers on the chemistry and biology of bioactive natural products and has delivered in excess of 150 invited lectures at international conferences, universities and research institutes. He is the recipient of several awards and prizes including the Gabor Medal (2009) and a Wolfson Research Merit Award (2013-2018) from the Royal Society, the 2009 Hickinbottom Award of the Royal Society of Chemistry, the 2007 Fleming Prize Lecture of the Society for General Microbiology, the 2007 Wain Medal Lecture of the University of Kent, the 2002 Meldola Medal and Prize of the Royal Society of Chemistry and the 1998 GlaxoWellcome Postdoctoral Fellowship. In 2011, he was elected as a Fellow of the Royal Society of Chemistry (FRSC) and a Fellow of the Royal Society of Biology (FRSB).

Challis is currently a commissioning editor for Natural Product Reports, the premier review journal in the natural products field, and serves on the editorial advisory boards for the Journal of Industrial Microbiology and Biotechnology, Antibiotics and Synthetic and Systems Biotechnology. He previously served as a member of the editorial advisory board for Current Drug Discovery Technologies (2008-2014). He was a core member of the Biotechnology and Biological Sciences Research Council's Committee D (Molecules, Cells and Industrial Biotechnology) from 2012-2015 and has also served as a member of advisory committees for industrial biotechnology (2010) and metagenomics (2012-2013) for this research council. He is currently a member of the management board for BBSRC's NPRONET network in industrial biotechnology and bioenergy, and has served on the organising committee for all five of the Royal Society of Chemistry's highly successful Directing Biosynthesis series of International Conferences.